Jounce Therapeutics: Q1 Earnings Insights


Jounce Therapeutics JNCE reported its Q1 earnings results on Thursday, May 5, 2022 at 06:30 AM.

Here's what investors need to know about the announcement.


Jounce Therapeutics missed estimated earnings by 26.32%, reporting an EPS of $-0.72 versus an estimate of $-0.57.

Revenue was down $1.54 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.27 which was followed by a 4.16% drop in the share price the next day.

Here's a look at Jounce Therapeutics's past performance:


Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate -0.32 -0.44 -0.36 -0.41
EPS Actual -0.59 -0.59 -0.08 -0.58
Revenue Estimate 12.31M 6.48M 8.18M 11.81M
Revenue Actual 0 0 25.37M 1.54M

To track all earnings releases for Jounce Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Posted In: EarningsNewsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!